[ad_1]
Fauci added that “by next December, the vaccine could be licensed for emergency use by the US Food and Drug Administration.”
This means, according to the American expert, that “there are doses that will be available to people who are classified as priority.”
The results of the initial trials of the vaccine, the American company “Pfizer” and its German partner, “Biontech”, showed a success rate of more than 90 percent.
“Pfizer” and “Biontech” seek to obtain approval from the relevant authorities for the use of the vaccine by the end of November.
And scientists and infectious disease specialists felt that the results of the initial vaccine trials exceeded expectations.
Regarding the use of masks, Fauchi said that “new studies have shown that they protect you and others from you”, noting that it is a “two-way street.”
He continued: “Putting on the muzzle prevents air droplets from escaping from you to protect others, as well as protecting you from droplets coming towards you.”
The American expert concluded that “social distancing measures, washing hands and wearing masks are very effective.”
Fauci expressed optimism that “the vaccine is coming soon.”